Total Payments
$8.9M
2023 Payments
$46.10
Companies
10
Transactions
21
Medicare Patients
816
Medicare Billing
$63,481
Payment Breakdown by Category
Other$8.9M (99.9%)
Consulting$4,500 (0.1%)
Food & Beverage$733.69 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8.9M | 4 | 99.9% |
| Consulting Fee | $4,500 | 1 | 0.1% |
| Food and Beverage | $733.69 | 16 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ethicon Inc. | $8.9M | 4 | $0 (2020) |
| Allergan Inc. | $4,826 | 5 | $0 (2018) |
| Alimera Sciences, Inc. | $125.00 | 1 | $0 (2017) |
| Mallinckrodt Enterprises LLC | $102.87 | 5 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $67.16 | 1 | $0 (2017) |
| Astellas Pharma US Inc | $30.13 | 1 | $0 (2023) |
| Genentech, Inc. | $28.97 | 1 | $0 (2017) |
| Biogen, Inc. | $20.83 | 1 | $0 (2022) |
| Sun Pharmaceutical Industries Inc. | $16.77 | 1 | $0 (2019) |
| Ocular Therapeutix, Inc. | $15.97 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $46.10 | 2 | Astellas Pharma US Inc ($30.13) |
| 2022 | $20.83 | 1 | Biogen, Inc. ($20.83) |
| 2020 | $398,193 | 1 | Ethicon Inc. ($398,193) |
| 2019 | $8.5M | 8 | Ethicon Inc. ($8.5M) |
| 2018 | $4,843 | 6 | Allergan Inc. ($4,826) |
| 2017 | $221.13 | 3 | Alimera Sciences, Inc. ($125.00) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $30.13 | General |
| 09/07/2023 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 12/10/2022 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $20.83 | General |
| 07/08/2020 | Ethicon Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $398,193.32 | General |
| 10/29/2019 | Sun Pharmaceutical Industries Inc. | CEQUA (Drug), BROMSITE, XELPROS | Food and Beverage | Cash or cash equivalent | $16.77 | General |
| Category: Ophthalmology | ||||||
| 07/15/2019 | Ethicon Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $31,095.04 | General |
| 07/15/2019 | Ethicon Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $157.04 | General |
| 06/26/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 06/13/2019 | Ethicon Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $8,443,625.03 | General |
| 05/01/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 03/21/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 01/03/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 10/02/2018 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 07/18/2018 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: RETINA | ||||||
| 05/31/2018 | Allergan Inc. | OZURDEX (Drug) | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| Category: RETINA | ||||||
| 04/21/2018 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $134.27 | General |
| Category: RETINA | ||||||
| 04/21/2018 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $101.61 | General |
| Category: RETINA | ||||||
| 04/21/2018 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $77.70 | General |
| Category: RETINA | ||||||
| 11/11/2017 | Alimera Sciences, Inc. | Iluvien (Biological) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Ophthalmology | ||||||
| 11/10/2017 | Valeant Pharmaceuticals North America LLC | LOTEMAX GEL (Drug), OPHTHALMIC INSTRUMENTS, STELLARIS | Food and Beverage | In-kind items and services | $67.16 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/26/2017 | Genentech, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $28.97 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 224 | 331 | $136,620 | $20,308 |
| 2022 | 8 | 234 | 288 | $63,005 | $21,929 |
| 2021 | 7 | 138 | 176 | $49,110 | $10,014 |
| 2020 | 6 | 220 | 267 | $96,385 | $11,230 |
Total Patients
816
Total Services
1,062
Medicare Billing
$63,481
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 67028 | Injection of drug into eye | Office | 2023 | 13 | 56 | $84,000 | $5,695 | 6.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 38 | $9,000 | $4,095 | 45.5% |
| 92134 | Imaging of retina | Office | 2023 | 48 | 90 | $18,000 | $3,160 | 17.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 20 | 20 | $4,000 | $2,266 | 56.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $2,925 | $1,419 | 48.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 16 | $2,750 | $1,371 | 49.8% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 17 | 18 | $2,970 | $1,068 | 35.9% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 58 | 69 | $12,075 | $974.42 | 8.1% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 11 | 12 | $900.00 | $260.96 | 29.0% |
| 93890 | Ultrasound of within the brain blood flow following medication | Office | 2022 | 18 | 18 | $7,200 | $4,259 | 59.2% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2022 | 18 | 18 | $7,200 | $4,228 | 58.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 43 | $5,375 | $3,608 | 67.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 31 | $6,200 | $3,299 | 53.2% |
| 92134 | Imaging of retina | Office | 2022 | 47 | 78 | $15,600 | $2,786 | 17.9% |
| 93892 | Ultrasound of within the brain blood flow for blood clots | Office | 2022 | 18 | 18 | $7,200 | $2,092 | 29.1% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 60 | 70 | $12,250 | $988.89 | 8.1% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 12 | 12 | $1,980 | $668.92 | 33.8% |
| 67028 | Injection of drug into eye | Office | 2021 | 15 | 24 | $25,920 | $2,647 | 10.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 24 | $3,000 | $2,125 | 70.8% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 39 | 55 | $8,900 | $2,098 | 23.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 13 | 13 | $3,680 | $1,327 | 36.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2021 | 13 | 20 | $1,990 | $1,148 | 57.7% |
| 92202 | Extended examination of eye with drawing of optic nerve and surrounding area (macula) | Office | 2021 | 26 | 27 | $4,725 | $387.74 | 8.2% |
| 92201 | Extended examination of eye with drawing of retina | Office | 2021 | 13 | 13 | $895.00 | $281.16 | 31.4% |
| 67028 | Injection of drug into eye | Office | 2020 | 36 | 54 | $62,100 | $3,677 | 5.9% |
About Dr. David Rubaltelli, M.D
Dr. David Rubaltelli, M.D is a Ophthalmology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962460931.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Rubaltelli, M.D has received a total of $8.9M in payments from pharmaceutical and medical device companies, with $46.10 received in 2023. These payments were reported across 21 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($8.9M).
As a Medicare-enrolled provider, Rubaltelli has provided services to 816 Medicare beneficiaries, totaling 1,062 services with total Medicare billing of $63,481. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Brooklyn, NY
- Active Since 05/01/2006
- Last Updated 01/18/2012
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1962460931
Products in Payments
- OZURDEX (Drug) $4,826
- Iluvien (Biological) $125.00
- ACTHAR (Biological) $102.87
- LOTEMAX GEL (Drug) $67.16
- Lucentis (Biological) $28.97
- CEQUA (Drug) $16.77
- DEXTENZA (Drug) $15.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Brooklyn
Dr. Irene Gladstein, M.d, M.D
Ophthalmology — Payments: $106,815
Ophthalmology $106,815
Mr. Raphael Rosenbaum, M.d, M.D
Ophthalmology — Payments: $40,149
Ophthalmology $40,149
Dr. Leonard Bley, M.d, M.D
Ophthalmology — Payments: $23,405
Ophthalmology $23,405
Dr. Bradley Phillips, M.d, M.D
Ophthalmology — Payments: $16,804
Ophthalmology $16,804
Joseph Zelefsky, Md, MD
Ophthalmology — Payments: $12,170
Ophthalmology $12,170
Stanley Bykov, Md, MD
Ophthalmology — Payments: $11,870
Ophthalmology $11,870